D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Praxis Precision Medicines
PRAX
$8.25B
| $645K | ﹤0.01% |
18,937
+12,475
| +193% | +$622K |
|
3727
Dorian LPG
LPG
$1.9B
| $644K | ﹤0.01% |
47,421
+13,971
| +42% | +$210K |
|
3728
Moelis & Co
MC
$5.1B
| $644K | ﹤0.01% |
19,039
+12,123
| +175% | +$508K |
|
3729
MYR Group
MYRG
$5.31B
| $644K | ﹤0.01% |
7,596
-100
| -1% | -$9.16K |
|
3730
CALL
Welltower
WELL
$172B
| $643K | ﹤0.01% |
10,000
| – | – |
|
|
KALV
3731
DELISTED
KalVista Pharmaceuticals
KALV
| $642K | ﹤0.01% |
44,269
-10,707
| -19% | -$150K |
|
|
PFTA
3732
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
| $641K | ﹤0.01% |
65,049
+4
| +0% | +$39 |
|
3733
Center Bancorp
CNOB
$1.66B
| $638K | ﹤0.01% |
27,663
+5,153
| +23% | +$132K |
|
3734
Expensify
EXFY
$173M
| $638K | ﹤0.01% |
42,900
-30,989
| -42% | -$578K |
|
|
CLLS
3735
Cellectis
CLLS
$286M
| $637K | ﹤0.01% |
278,327
+6,778
| +2% | +$20.5K |
|
3736
PUT
Macerich
MAC
$7.52B
| $635K | ﹤0.01% |
80,000
| – | – |
|
3737
PUT
Pan American Silver
PAAS
$18.2B
| $635K | ﹤0.01% |
40,000
| – | – |
|
3738
Organogenesis Holdings
ORGO
$326M
| $631K | ﹤0.01% |
194,778
+43,523
| +29% | +$197K |
|
3739
Zentalis Pharmaceuticals
ZNTL
$329M
| $631K | ﹤0.01% |
29,112
-25,633
| -47% | -$701K |
|
3740
BrightView Holdings
BV
$1.3B
| $630K | ﹤0.01% |
79,326
+22,455
| +39% | +$240K |
|
3741
Crocs
CROX
$6.75B
| $630K | ﹤0.01% |
9,170
-262,460
| -97% | -$18.2M |
|
|
NOTV
3742
DELISTED
Inotiv
NOTV
| $624K | ﹤0.01% |
37,061
-6,843
| -16% | -$126K |
|
3743
QCR Holdings
QCRH
$1.69B
| $622K | ﹤0.01% |
12,205
+6,774
| +125% | +$379K |
|
3744
PUT
BlueLinx
BXC
$465M
| $621K | ﹤0.01% |
10,000
-10,000
| -50% | -$721K |
|
3745
Watsco Inc
WSO
$15.1B
| $621K | ﹤0.01% |
2,411
+356
| +17% | +$96.5K |
|
3746
Duluth Holdings
DLTH
$163M
| $620K | ﹤0.01% |
87,967
+10,174
| +13% | +$90.9K |
|
|
AD
3747
Array Digital Infrastructure
AD
$3.03B
| $620K | ﹤0.01% |
23,826
-7,483
| -24% | -$214K |
|
|
CTRA
3748
PUT
DELISTED
Coterra Energy
CTRA
| $619K | ﹤0.01% |
+23,700
| New | +$679K |
|
3749
CALL
Asana
ASAN
$1.89B
| $618K | ﹤0.01% |
27,800
+17,800
| +178% | +$382K |
|
3750
Old Republic International
ORI
$10.8B
| $617K | ﹤0.01% |
29,475
+2,996
| +11% | +$67.4K |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.